Microenvironment influence on human colon adenocarcinoma phenotypes and matrix metalloproteinase-2, p53 and β-catenin tumor expressions from identical monoclonal cell tumor in the orthotopic model in athymic nude rats

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 3, 2014, Pages 309-316

  Priolli, Denise Gonçalves ^a   Abrantes, Ana Margarida ^b   Neves, Silvia ^b   Gonçalves, Ana Cristina ^b   Lopes, Camila Oliveira ^a   Martinez, Natalia Peres ^a   Cardinalli, Izilda Aparecida ^a   Sarmento Ribeiro, Ana Bela ^b   Botelho, Maria Filomena ^b  

^a Universidade Sao Francisco Centro de Ciencias Biologicas e da Saude   (Brazil)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

catenin; Adenocarcinoma; Colonic neoplasms; Matrix metalloproteinase; Nude; P53; Radionuclide imaging; Rats; Tumor microenvironment; Xenograft model antitumor assays

Indexed keywords

ADENOCARCINOMA; ANIMALS; BETA CATENIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; PHENOTYPE; RATS; RATS, NUDE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84894141349     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.869350     Document Type: Article

References (34)

1. Buffill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779.88.
2. Gervaz P, Bouzourene H, Cerottini JP, Chaubert P, Benhattar J, Secic M, et al. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum 2001;44:364.72.
3. Martinez CAR, Priolli DG, Cardinalli IA, Pereira JA, Portes AV, Margarido NF. Influencia da localizacao do tumor na expressao tecidual da proteina p53 em doentes com cancer colorretal. Estudo de 100 casos. Rev Col Bras Cir 2008;35:235.43.
4. Distler P, Holt PR. Are right and left-sided neoplasms distinct tumors? Dig Dis 1997;15:302.11.
5. Obrand DI, Gordon PH. Continued change in the distribution of colorectal carcinoma. Br J Surg 1998;85:246.8.
6. Minoo P, Zlobec I, Peterson M, Terracciano L, Lugli A. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 2010;37:707.18.
7. Li FY, Lai MD. Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 2009;10:219.29.
8. Gervaz P, Buhler L, Scheiwiller A, Morel P. A tale of two colons and two cancers. Distinct carcinogenesis and clinical outcome according to location proximal or distal to the splenic flexure. Swiss Surg 2003;9:3.7.
9. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003;12:755.62.
10. Raut CP, Pawlik TM, Rodriguez-Bigas MA. Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mutat Res 2004;568:275.82.
11. Ribeiro Junior U, Alves VA, Souza PMB, Ribeiro AVS, Rawet V, Nonogaki S, et al. Correlacao das proteinas p53 e KI-67 com o prognostico de pacientes com adenocarcinoma de reto distal. Rev bras Coloproct 2000;20:246.54.
12. Pantelouris EM. Absence of thymus in a mouse mutant. Nature 1968;217:370.1.
13. Fidler IJ. Orthotopic implantation ofhumancolon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 1991;10:229.3.
14. Jin H, Liu X, Li VK, Ding Y, Yun S, Liu F, et al. A simple colostomy implantation model for evaluating colon cancer. Int J Colorectal Dis 2009;24:41.7.
15. Priolli DG, Abrantes AM, Neves S, Batista JN, Cardinalli IC, Botelho MF. A novel model of distal colon cancer in athymic mice. Acta Cirurg Bras 2012;27:355.60.
16. Chen S, Liu J, Li G, Mo F, Xu X, Zhang T, et al. Altered distribution of betacatenin and prognostic roles in colorrectal carcinogenesis. Scand J Gastroenterol 2008;43:456.64.
17. Majumdar SR, Fletcher RH, Evans AT. How does colorectal cancer present? symptoms, duration, and clues to location. Am J Gastroenterol 1999;94:3039.45.
18. Marchenko ND, Marchenko GN, Weinreb RN, Lindsey JD, Kyshtoobayeva A, Crawford HC, et al. Beta-Catenin regulates the gene of MMP-26, a novel matrix metalloproteinase expressed both in carcinomas and normal epithelial cells. Int J Biochem Cell Biol 2004;36:942.56.
19. SPCAL. Sociedade Portuguesa de Ciencias em Animais de Laboratorio. Saude. http://www.spcal.pt. Cited2013July.
20. Gutman M, Singh RK, Yoon S, Xie K, Bucana CD, Fidler IJ. Leukocyte-induced angiogenesis and subcutaneous growth of B16 melanoma. Cancer Biother 1994;9:163.70.
21. Martinez NP, Kanno DT, Aires J, Cardinalli IA, Priolli DG. b-Catenin and e-cadherin tissue content as a prognostic marker in left-side colorectal cancer. Cancer Biomark 2010-2011;8:129.35.
22. Guenaga KF, Lustosa ASS, Saad SS, Saconato H, Matos D. Ileostomy or colostomy for temporary decompression of colorectal anastomosis: systematic review and meta-analysis. Acta Cir Bras 2008;23:294.303.
23. Cui JH, Krueger U, Henne-Bruns D, Kremer B, Kalthoff H. Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases. World J Gastroenterol 2001;7:381.6.
24. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad O. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 2004;40:1593.8.
25. Rygaard K, Sorenson GD, Pettengill OS, Cate CC, Spang-Thomsen M. Abnormalities in structure and expression of the retinoblastoma gene in small cell lung cancer cell lines and xenografts in nude mice. Cancer Res 1990;50:5312.17.
26. Crawford S. Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. Front Pharmacol 2013;25:68.
27. Mu Y, Chen Y, Zhang G, Zhan X, Li Y, Liu T, et al. Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics. Electrophoresis 2013;34:1679.92.
28. Nguyen AV, Albers CG, Holcombe RF. Differentiation of tubular and villous adenomas based on Wnt pathwayrelated gene expression profiles. Int J Mol Med 2010;26:121.5.
29. Oloumi A, McPhee T, Dedhar S. Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophys Acta 2004;1691:1.15.
30. Diez M, Medrano M, Muguerza JM, Ramos P, Hernandez P, Villeta R, et al. Influence of tumor localization on the prognostic value of p53 protein in colorectal adenocarcinomas. Anticancer Res 2000;20:3907.12.
31. Soong R, Powell B, Elsaleh H, Gnanasampanthan G, Smith DR, Goh HS, et al. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumor site, stage, adjuvant chemotherapy and type mutation. Eur J Cancer 2000;36:2053.60.
32. Paluszkiewicz P, Berbeć H, Pawówska-Wakowicz B, Cybulski M, Paszkowska A. p53 protein accumulation in colorectal cancer tissue has prognostic value only in left-sided colon tumours. Cancer Detect Prev 2004;28:252.9.
33. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403.8.
34. Cha YH, Kim NH, Park C, Yook JI. MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling. Cell cycle 2012;11:1273.81.